Skip to Content

Notice

National Cancer Institute; Notice of Closed Meetings

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications/contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; Centers of Cancer Nanotechnology Excellence (CCNE).

Date: March 31-April 2, 2015

Time: 5:00 p.m. to 6:00 p.m.

Agenda: To review and evaluate contract proposals.

Place: Bethesda North Marriott Hotel and Conference Center; 5701 Marinelli Road; North Bethesda, MD 20852.

Contact Person: Jeffrey E. DeClue, Ph.D.; Scientific Review Officer; Research Technology and Contract Review Branch; Division of Extramural Activities; National Cancer Institute; 9609 Medical Center Drive, Room 7W238; Bethesda, MD 20892-9750; 240-276-6371; decluej@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel; Omnibus R03 & R21 SEP-6.

Date: April 10, 2015.

Time: 9:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate grant applications.

Place: National Cancer Institute Shady Grove; 9609 Medical Center Drive, Room 7W030; Rockville, MD 20850; (Telephone Conference Call).

Contact Person: Caron A. Lyman, Ph.D. Chief, Scientific Review Officer; Research Programs Review Branch; Division of Extramural Activities; National Cancer Institute, NIH; 9609 Medical Center Drive, Room 7W126; Bethesda, MD 20892-9750; 240-276-6348; lymanc@mail.nih.gov.

Name of Committee: National Cancer Institute Special Emphasis Panel; Molecular and Cellular Characterization of Screen-Detected Lesions.

Date: April 13, 2015.

Time: 8:00 a.m. to 6:00 p.m.

Agenda: To review and evaluate grant applications.

Place: Bethesda North Marriott Hotel & Conference Center; 5701 Marinelli Road; North Bethesda, MD 20852.

Contact Person: Caron A. Lyman, Ph.D.; Chief, Scientific Review Officer; Research Programs Review Branch; Division Of Extramural Activities; National Cancer Institute, NIH; 9609 Medical Center Drive, Room 7W126; Bethesda, MD 20892-9750; 240-276-6348; lymanc@mail.nih.gov.

Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/​advisory/​sep/​sep.htm, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Start Signature

Dated: February 18, 2015.

Melanie J. Gray,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2015-03633 Filed 2-23-15; 8:45 am]

BILLING CODE 4140-01-P